Bavituximab, referred to as TRWH-783, represents an innovative immunotherapy approach targeting phosphatidylserine (PS). PS is usually a cellular lipid present within cell membranes; however, it's commonly displayed on https://poppiejrng835823.wikicommunications.com/user